| 41051 |
A |
II |
2024/12/31
|
ZHEJIANG HENGKANG PHARMACEUTICAL CO LTD |
DEFERASIROX |
| 41064 |
A |
IV |
2024/12/31
|
ZHEJIANG AUSUN PHARMACEUTICAL CO LTD |
CALCIUM SACCHARATE |
| 41073 |
A |
II |
2024/12/31
|
BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD |
SAXAGLIPTIN INTERMEDIATE SGA
|
| 41074 |
A |
II |
2024/12/31
|
ZYDUS LIFESCIENCES LTD |
DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE USP |
| 41077 |
A |
II |
2024/12/31
|
MAITHRI DRUGS PRIVATE LTD |
SAPROPTERIN DIHYDROCHLORIDE |
| 41081 |
A |
II |
2024/12/31
|
DR REDDYS LABORATORIES LTD |
MAVACAMTEN |
| 41086 |
A |
II |
2024/12/31
|
METROCHEM API PRIVATE LTD |
VORTIOXETINE HYDROCHLORIDE |
| 41088 |
A |
II |
2024/12/31
|
SHANDONG LURUI PHARMACEUTICAL CO LTD |
METFORMIN HYDROCHLORIDE |
| 41089 |
A |
II |
2024/12/31
|
TRANSGEN BIOTECH CO LTD |
TRANSSTEM® CHEMICALLY DEFINED XENO-FREE CELL CRYOPRESERVATION MEDIUM III—DMSO FREE, PROTEIN FREE
|
| 41091 |
A |
II |
2024/12/31
|
METROCHEM API PRIVATE LTD |
VORTIOXETINE HYDROBROMIDE |
| 41151 |
A |
II |
2024/12/31
|
MSN LIFE SCIENCES PRIVATE LTD |
SAMIDORPHAN L-MALATE |
| 41157 |
A |
II |
2024/12/31
|
OPTIMUS DRUGS PRIVATE LTD |
LINEZOLID USP (FORM-III) |
| 40932 |
A |
II |
2024/12/31
|
ZHEJIANG APELOA JIAYUAN PHARMACEUTICAL CO LTD |
BUPROPION HYDROBROMIDE |
| 40952 |
A |
II |
2024/12/31
|
HETERO DRUGS LTD |
ATOVAQUONE (FORM-A), PROCESS II
|
| 40974 |
A |
II |
2024/12/31
|
JIANGSU NHWA PHARMACEUTICAL CO LTD |
BUSPIRONE HYDROCHLORIDE USP |
| 40977 |
A |
II |
2024/12/31
|
EMCURE PHARMACEUTICALS LTD |
HYDROXYZINE PAMOATE USP |
| 40982 |
A |
II |
2024/12/31
|
HETERO DRUGS LTD |
RIFAXIMIN |
| 41007 |
A |
II |
2024/12/31
|
ALEMBIC PHARMACEUTICALS LTD |
RIFAXIMIN |
| 41012 |
A |
II |
2024/12/31
|
BIOPHORE INDIA PHARMACEUTICALS PVT LTD |
RUXOLITINIB PHOSPHATE |
| 41013 |
A |
II |
2024/12/31
|
BIOPHORE INDIA PHARMACEUTICALS PVT LTD |
NAPHAZOLINE NITRATE |
可点击列名称排序
请输入需要查询的关联主题/药物名称（英文），DMF持有人（英文），DMF号码